171 related articles for article (PubMed ID: 26666724)
1. [Diffuse large B-cell lymphoma occurring in a Waldenström macroglobulinemia patient with central nervous system infiltration].
Hayashi Y; Sata H; Akuta K; Toda J; Kusakabe S; Ueda T; Ueda Y; Fujita J; Tadokoro S; Maeda T; Nishimura J; Shibayama H; Oritani K; Kanakura Y
Rinsho Ketsueki; 2015 Nov; 56(11):2351-6. PubMed ID: 26666724
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Bing-Neel Syndrome Accompanying Waldenström's Macroglobulinemia with R-MPV: A Case Report.
Kikukawa Y; Yamamura-Fujimoto A; Endo S; Miyagawa E; Kawano Y; Ueno S; Mitsuya H; Hata H; Okuno Y
J Clin Exp Hematop; 2015; 55(2):113-9. PubMed ID: 26490525
[TBL] [Abstract][Full Text] [Related]
3. Clonally related transformation from Waldenström macroglobulinemia to diffuse large B-cell lymphoma with central nervous system involvement at diagnosis: a case report and literature review.
Chen H; Zhao D; Wang Z; Zhang W; Wang W
Clin Exp Med; 2023 Dec; 23(8):5473-5476. PubMed ID: 37921873
[TBL] [Abstract][Full Text] [Related]
4. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
[TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
[TBL] [Abstract][Full Text] [Related]
6. [Waldenström macroglobulinemia with diffuse large B-cell lymphoma that developed from a different B-cell clone].
Kogawa K; Sato T; Inohara T; Kuribayashi K; Yamauchi N; Kato J; Sakamaki S; Niitsu Y; Sato M
Rinsho Ketsueki; 1999 Oct; 40(10):1116-23. PubMed ID: 10565231
[TBL] [Abstract][Full Text] [Related]
7. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
[TBL] [Abstract][Full Text] [Related]
8. Bing-Neel Syndrome: An Initial Manifestation of Waldenstrom Macroglobulinemia.
Lee MS; Sathe S; Valasapalli S; Grosse Perdekamp M
Cureus; 2021 Nov; 13(11):e19402. PubMed ID: 34926004
[TBL] [Abstract][Full Text] [Related]
9. Orbital involvement in Bing-Neel syndrome.
Stacy RC; Jakobiec FA; Hochberg FH; Hochberg EP; Cestari DM
J Neuroophthalmol; 2010 Sep; 30(3):255-9. PubMed ID: 20548243
[TBL] [Abstract][Full Text] [Related]
10. Bing-Neel syndrome: Two unexpected cases and a review of the literature.
Van Cauwenberge MG; Depreter B; Dumoulin EN; Emmerechts J; Nollet F; Vanopdenbosch LJ
J Neurol Sci; 2015 Sep; 356(1-2):19-26. PubMed ID: 26159625
[TBL] [Abstract][Full Text] [Related]
11. Bing-Neel Syndrome Successfully Treated with Tirabrutinib.
Oyama T; Taoka K; Chiba A; Matsuda K; Maki H; Masamoto Y; Kurokawa M
Intern Med; 2022 Dec; 61(23):3575-3579. PubMed ID: 35569989
[TBL] [Abstract][Full Text] [Related]
12. Multiple brain tumors of diffuse large B cell lymphoma in a patient with Waldenström's macroglobulinemia/ lymphoplasmacytic lymphoma: PCR and DNA sequence analysis show evidence of differences in clonality of the two B cell malignancies.
Tojo K; Hattori T; Ito T; Asano N; Sano K; Suzuki T; Maruyama K
Intern Med; 2004 Oct; 43(10):990-6. PubMed ID: 15575254
[TBL] [Abstract][Full Text] [Related]
13. Are you sure this is Waldenstrom macroglobulinemia?
Ghobrial IM
Hematology Am Soc Hematol Educ Program; 2012; 2012():586-94. PubMed ID: 23233639
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.
Castillo JJ; D'Sa S; Lunn MP; Minnema MC; Tedeschi A; Lansigan F; Palomba ML; Varettoni M; Garcia-Sanz R; Nayak L; Lee EQ; Rinne ML; Norden AD; Ghobrial IM; Treon SP
Br J Haematol; 2016 Mar; 172(5):709-15. PubMed ID: 26686858
[TBL] [Abstract][Full Text] [Related]
15. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
16. Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Jafri H; Khan I; Sidda A; Khan NAJ; Kheetan M; Griswold D; Pacioles T
J Investig Med High Impact Case Rep; 2021; 9():23247096211021228. PubMed ID: 34078157
[TBL] [Abstract][Full Text] [Related]
17. Diffuse large cell lymphoma occurring in a patient with Waldenström's macroglobulinemia. Evidence for the two different clones in Richter's syndrome.
Chubachi A; Ohtani H; Sakuyama M; Nimura T; Mamiya S; Saitoh M; Watanuki T; Miura AB
Cancer; 1991 Aug; 68(4):781-5. PubMed ID: 1906774
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing, imaging, and successfully treating a debilitating case of Bing-Neel syndrome: A multidisciplinary feat.
Kerley RN; O'Donnell N; Lynott F; Mulcahy R; Hennessy B
Clin Case Rep; 2023 May; 11(5):e7296. PubMed ID: 37151950
[TBL] [Abstract][Full Text] [Related]
19. [(Neurological CPC-59). A 65-year-old man with a history of gastric cancer who presented progressive loss of vision, memory loss and consciousness disturbance].
Nohara C; Matsumine H; Suzuki K; Saito A; Ohtaka M; Mori H; Suda K; Kondo T; Hayakawa M; Kanai J; Mizuno Y
No To Shinkei; 1997 Nov; 49(11):1041-51. PubMed ID: 9396038
[TBL] [Abstract][Full Text] [Related]
20. Sanctuary site central nervous system relapse-refractory DLBCL responding to nivolumab and lenalidomide.
Madabhavi IV; Revannasiddaiah S; Sarkar MS; Modi MG
Oral Oncol; 2019 Jun; 93():122-124. PubMed ID: 31010638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
